Robotic Biopsies for Lung Cancer Diagnosis
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 40 (estimated)
- Sponsor
- Mayo Clinic · Other
This trial is looking for adults who are at moderate to high risk for lung cancer or have suspected metastatic disease. Participants will provide samples of blood, saliva, and archived tissue to help improve cancer diagnosis and treatment plans.
You may be able to join if
- I am 18 years old or older
- I am scheduled for a bronchoscopy
- I have a moderate to high risk of lung cancer
- I can provide a blood or saliva sample
- I can provide archived tissue
- I can understand and follow study requirements
- I can give informed consent
You may not be able to join if
- I have a situation that would limit my compliance with study requirements
- I am currently institutionalized
- I am pregnant
- I have had genetic testing with a 40+ multi-gene panel in the last year
- I have had somatic tissue testing within the last 3 months
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.
Loading trial locations…
No contact information available.